Miaa-376 Verified
Studies have shown that MIAA-376 can bind to and inhibit the activity of BCL-2, leading to an increase in apoptosis in certain cancer cells. This suggests that MIAA-376 may have potential as a therapeutic agent for the treatment of cancers that are characterized by overexpression of BCL-2.
To further unravel the mystery of MIAA-376, future research efforts may focus on: MIAA-376
